Oxymetholones, marketed as Anadrol, is a synthetic anabolic steroide developed in 1960 by Zoltan 'Anadrol Z' F. Its primary clinical applications include treatment of osteoporosis and anaemia, as well as stimulating muscle growth in malnourished or underdeveloped patients. The drug was approved for human use by the FDA. Later, non-steroide drugs such as epoetin alfa were developed and proven to be more effective as a treatment for anaemia and osteoporosis without the side effects of oxymetholones. The drug remained available despite this and eventually found a new use in treating HIV wasting syndrome. Presented most commonly as a 50 mg tablet, oxymetholones is one of the strongest androgenic steroide available. Similarly, it also poses the greatest risk of side effects of any steroide. Despite very low binding affinity with the androgen receptor, oxymetholones is highly effective in promoting extensive gains in body mass, mostly by greatly improving protein synthesis. For this reason, it is often used by bodybuilders and athletes. Many athletes also use oxymetholones as a method of protection for the joints under heavy loads. Due to the high water retention users experience from this drug, it similarly lubricates the joints and helps protect from injury. Oxymetholone is widely considered by bodybuilders to have the strongest anabolic effect out of all oral steroide available.

Related Keywords : oxymetholones